Literature DB >> 8689171

Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis.

H Kashiwagi1, A D Spigelman, I C Talbot, R K Phillips.   

Abstract

Duodenal polyps and tumours of different histology from patients with familial adenomatous polyposis (FAP) were examined for p53 overexpression to determine the genetic events in duodenal tumorigenesis. Samples from endoscopic biopsy specimens of 152 duodenal adenomatous polyps (taken from 79 patients) and from 13 surgically resected adenomatous polyps or cancers (taken from nine patients) were studied by routine histological examination and immunohistochemistry. p53 was overexpressed in: 0 per cent of normal mucosa samples (none of 29), 25 per cent of tubular adenomas (28 of 111), 72 per cent of tubulovillous and villous adenomas (13 of 18) and 100 per cent of duodenal cancers (seven of seven); and in 28 per cent of mildly dysplastic polyps (32 of 113), 56 per cent of moderately or severely dysplastic polyps (nine of 16) and 100 per cent of cancers (seven of seven). Overexpression of p53 increased with passage down the adenoma-carcinoma pathway and might therefore be a valuable additional marker of risk for duodenal malignancy in patients with FAP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689171

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

Review 1.  Prevention and management of duodenal polyps in familial adenomatous polyposis.

Authors:  L A A Brosens; J J Keller; G J A Offerhaus; M Goggins; F M Giardiello
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis.

Authors:  James R A Skipworth; Clare Morkane; Dimitri Aristotle Raptis; Soumil Vyas; Steven W Olde Damink; Charles J Imber; Stephen P Pereira; Massimo Malago; Nicholas West; Robin K S Phillips; Sue K Clark; Arjun Shankar
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

Review 3.  Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.

Authors:  Michelle C Gallagher; Robin K S Phillips; Steffen Bulow
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 4.  Gastroduodenal lesions in familial adenomatous polyposis.

Authors:  H Kashiwagi; A D Spigelman
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.

Authors:  R K S Phillips; M H Wallace; P M Lynch; E Hawk; G B Gordon; B P Saunders; N Wakabayashi; Y Shen; S Zimmerman; L Godio; M Rodrigues-Bigas; L-K Su; J Sherman; G Kelloff; B Levin; G Steinbach
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.